Victoria Sinibaldi

Research Associate

1987 …2018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Victoria Sinibaldi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Suramin Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Prostate-Specific Antigen Medicine & Life Sciences
Castration Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences
hexamethylene bisacetamide Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1987 2018

Kidney cancer: Toxicity management, symptom control, and palliative care

Sinibaldi, V., Pratz, C. F. & Yankulina, O., Dec 20 2018, In : Journal of Clinical Oncology. 36, 36, p. 1-7 7 p.

Research output: Contribution to journalReview article

Kidney Neoplasms
Palliative Care
Immunotherapy
Nursing Societies
Oncology Nursing

Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: An open-label, phase 2, multicohort study

Teply, B. A., Wang, H., Luber, B., Sullivan, R., Rifkind, I., Bruns, A., Spitz, A., DeCarli, M., Sinibaldi, V., Pratz, C. F., Lu, C., Silberstein, J. L., Luo, J., Schweizer, M. T., Drake, C. G., Carducci, M. A., Paller, C., Antonarakis, E., Eisenberger, M. & Denmeade, S. R., Jan 1 2017, (Accepted/In press) In : The Lancet Oncology.

Research output: Contribution to journalArticle

Castration
Androgens
Prostatic Neoplasms
Therapeutics
MDV 3100

Is there a "trial effect" on outcome of patients with metastatic renal cell carcinoma treated with sunitinib?

Keizman, D., Rouvinov, K., Sella, A., Gottfried, M., Maimon, N., Kim, J. J., Eisenberger, M., Sinibaldi, V., Peer, A., Carducci, M. A., Mermershtain, W., Leibowitz-amit, R., Weitzen, R. & Berger, R., 2016, In : Cancer Research and Treatment. 48, 1, p. 281-287 7 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Clinical Trials
Disease-Free Survival
Survival
Therapeutics

Outcome of patients with metastatic chromophobe renal cell carcinoma treated with sunitinib

Keizman, D., Sarid, D., Lee, J. L., Sella, A., Gottfried, M., Hammers, H., Eisenberger, M., Carducci, M. A., Sinibaldi, V., Neiman, V., Rosenbaum, E., Peer, A., Neumann, A., Mermershtain, W., Rouvinov, K., Berger, R. & Yildiz, I., Oct 1 2016, In : Oncologist. 21, 10, p. 1212-1217 6 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Disease-Free Survival
Survival
Neutrophils
Lymphocytes
Castration
Androgen Receptors
Prostatic Neoplasms
Disease-Free Survival
Antigens